| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/16/2004 | EP1100476B1 Formulations for the transdermal administration of fenoldopam |
| 06/16/2004 | EP1100433B1 Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type, containing boron nitride |
| 06/16/2004 | EP1098649B1 Method for stabilizing pharmaceutical compositions by special use of an antioxidant |
| 06/16/2004 | EP1082109B1 Oral formulation comprising biguanide and an organic acid |
| 06/16/2004 | EP1079810B1 Orally administrable compositions comprising cation cross-linked polysaccharide and a polymer digestible in the lower gastrointestinal tract |
| 06/16/2004 | EP1071466B1 Glycolipid creams |
| 06/16/2004 | EP1071413B1 Topical formulations for the treatment of nail fungal diseases |
| 06/16/2004 | EP1064942B1 Sustained release preparation of a macrolide |
| 06/16/2004 | EP1061947B1 Stabilized aqueous glucagon solutions comprising detergents |
| 06/16/2004 | EP1014961B1 Treatment of migraine headache using metoclopramide and an nsaid |
| 06/16/2004 | EP0977554B1 Confectionery compositions |
| 06/16/2004 | EP0902777B2 D-mannitol and its preparation |
| 06/16/2004 | EP0787003B1 Animal model system for the testing of drug candidates for the treatment of leukemia or hiv |
| 06/16/2004 | EP0760689B1 Method of manufacturing and storing solutions |
| 06/16/2004 | CN2620540Y Multipurpose medicinal magnetic patch |
| 06/16/2004 | CN1505683A Oligonucleotide - facilitated coalescence |
| 06/16/2004 | CN1505551A Mathod for preparing micro powder containing anti-agglomerated nanometer silver, micro powder produced by the mathod and its application |
| 06/16/2004 | CN1505524A Immunopotentiators |
| 06/16/2004 | CN1505523A Method for producing pellet and tablet |
| 06/16/2004 | CN1505521A Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof |
| 06/16/2004 | CN1505520A Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 06/16/2004 | CN1505519A Amphotericin B aqueous composition |
| 06/16/2004 | CN1505518A Use of sucralfate for the treatment of cervical erosion |
| 06/16/2004 | CN1505517A Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis |
| 06/16/2004 | CN1505515A Oral pharmaceutical composition of cefpodoxime proxetil |
| 06/16/2004 | CN1505513A Aqueous cilostazol preparation for injection |
| 06/16/2004 | CN1505512A A stable pharmaceutical formulation comprising torsemide modification II |
| 06/16/2004 | CN1505505A Composition for administration to mucosa and containing coenzyme Q as active ingredient |
| 06/16/2004 | CN1505503A Method for preparing submicron particle suspensions |
| 06/16/2004 | CN1505502A Fibrate-statin combinations with reduced fed-fasted effects |
| 06/16/2004 | CN1504478A Burnet general saponin extract , its preparation method and use |
| 06/16/2004 | CN1504242A Implantable delivery device with self adjustable exit port |
| 06/16/2004 | CN1504239A Improved carrier system for cyclosporin pharmaceutical compositions |
| 06/16/2004 | CN1504229A Immune toxin expelling powder for treating chronic kidney degeneration and uremia |
| 06/16/2004 | CN1504208A Gingko drop pill for prevention and treatment of cardiovascular and cerebrovascular disease |
| 06/16/2004 | CN1504204A Soft capsule whose main material is walnut oil, seed of spine date, fruit of magnoliavine |
| 06/16/2004 | CN1504195A Liposome injection liquid of hydrochloric acid daunerubicin and its process |
| 06/16/2004 | CN1504192A Powder and injection preparation of pharmaceutical composition for curing organic phosphorus compound poisoning |
| 06/16/2004 | CN1504191A Cucurbitacin lipsome preparation method and formulation |
| 06/16/2004 | CN1504187A Pharmaceutical composition containing fenofibrate with high efficacy for hyperlipemia, its preparation method and use |
| 06/16/2004 | CN1504186A Large volume injection liquid of ethylenediamine diaceturate and its preparation method |
| 06/16/2004 | CN1504185A 药物组合物 The pharmaceutical composition of |
| 06/16/2004 | CN1504184A Solid medicine composition and its preparation method |
| 06/16/2004 | CN1504183A Nanometertechnology preparation method of fat emulsion injection liquid |
| 06/16/2004 | CN1153965C Method and industrial process for determining dose-level characteristics of multiple unit system and application thereof |
| 06/16/2004 | CN1153777C Process for preparing a charcoal-GM1 complex |
| 06/16/2004 | CN1153587C Composition for preventing and treating epidemic diarrhea of egg-laying hen |
| 06/16/2004 | CN1153586C Composition for increasing egg-laying rate of hen |
| 06/16/2004 | CN1153571C External therapeutic composition for dermatitis |
| 06/16/2004 | CN1153570C Method and composition of an oral preparation of itraconazole |
| 06/16/2004 | CN1153567C Scale production method of forming microparticles |
| 06/16/2004 | CN1153565C Physically active antimicrobial gel for cosmetic products |
| 06/16/2004 | CN1153556C Transdermal/transmucosal plaster dispenser |
| 06/15/2004 | US6750331 Has improved texture and high stability and is in the form of foaming chewable tablets |
| 06/15/2004 | US6750249 Gradually release esculetin or its derivative in a controlled manner over a long period of time |
| 06/15/2004 | US6750237 Pharmaceutical formulations containing zolmitriptan |
| 06/15/2004 | US6750228 Uncontrolled breakdown of connective tissue by metalloproteases is a feature of many pathological conditions |
| 06/15/2004 | US6750210 Formulation containing novel anti-inflammatory androstane derivative |
| 06/15/2004 | US6750058 For treatment and prevention of human and animal diseases; in particular capable of dispensing to suitable target cells nucleic sequences, proteins, peptides and chemical substances via transfection |
| 06/15/2004 | US6749870 Compositions and methods for the control of smoking |
| 06/15/2004 | US6749869 Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection |
| 06/15/2004 | US6749868 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 06/15/2004 | US6749867 Drug-containing core surrounded by inert time-release coating that delays release of drug from core until expiration of a certain time period |
| 06/15/2004 | US6749866 Modulated release from biocompatible polymers |
| 06/15/2004 | US6749864 Stabilized pharmaceutical composition |
| 06/15/2004 | US6749863 Targeted liposome gene delivery |
| 06/15/2004 | US6749851 Applying radiation |
| 06/15/2004 | US6749849 Method for producing arachidonic acid |
| 06/15/2004 | US6749845 Modulated release particles for lung delivery |
| 06/15/2004 | US6749835 Hydroxy-di- or tricarboxylic acid, phospholipid, inorganic salt and active ingredient; nonagglomerating; avoiding or suspending lung's natural clearance mechanisms until drug delivery is complete; short and long term release |
| 06/15/2004 | US6749587 Modular infusion device and method |
| 06/15/2004 | US6748954 Such as by repeated compression; drug or combination of drugs is reversably bound to matrix; makes possible delivery of drug directly to site of wound or trauma in vivo |
| 06/15/2004 | CA2329800C Protein formulations |
| 06/15/2004 | CA2230551C Composition of external preparation and process for preparing the same |
| 06/15/2004 | CA2209432C Use of urea containing amino-alcohol derivatives in and for the preparation of cosmetic and dermatological compositions |
| 06/15/2004 | CA2088334C Fast dissolving tablet and its production |
| 06/13/2004 | CA2729967A1 Dermal, transdermal, mucosal or transmucosal ingredient delivery devices |
| 06/10/2004 | WO2004049358A2 Multifunctional particulate material, fluid, and composition |
| 06/10/2004 | WO2004049319A1 Read/write device for optical memory and method therefore |
| 06/10/2004 | WO2004049095A2 Betaine and salicylic acid compositions |
| 06/10/2004 | WO2004048575A2 Streptococcus pneumoniae surface polypeptides |
| 06/10/2004 | WO2004048432A2 Preparation of polyphosphazene microspheres |
| 06/10/2004 | WO2004048411A2 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion |
| 06/10/2004 | WO2004048287A1 Hardening bone compensate and remedy for skin defect using calcium phosphate sustainedly releasing zinc |
| 06/10/2004 | WO2004047977A1 Method for modifying microparticles and device for modifying microparticles |
| 06/10/2004 | WO2004047942A2 Method and apparatus for filtering and drying a product |
| 06/10/2004 | WO2004047881A1 Calcium phosphate carrying protein, process for producing the same and sustained release protein preparation, artificial bone and tissue enginerring scaffold using the same |
| 06/10/2004 | WO2004047872A2 Treatment of neurodegenerative disease through intracranial delivery of short interfering rna (sirna) |
| 06/10/2004 | WO2004047846A1 Oil/glycyrrhizin-containing surfactant phase type gel composition |
| 06/10/2004 | WO2004047844A1 Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain |
| 06/10/2004 | WO2004047841A1 Treatment of headache with antipsychotics delivered by inhalation |
| 06/10/2004 | WO2004047839A1 High concentration formulations of opioids and opioid derivatives |
| 06/10/2004 | WO2004047835A1 Use of pharmaceutical compositions containing ethyl esters of omega-3 polyunsaturated acids to prevent atrial fibrillation |
| 06/10/2004 | WO2004047822A1 Hydroxypropylmethylcellulose capsule preparation having teprenone encapsulated therein |
| 06/10/2004 | WO2004047820A1 Warm poultice |
| 06/10/2004 | WO2004047816A1 Selective cyclooxygenase-2 inhibitor patch |
| 06/10/2004 | WO2004047815A1 Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor, e.g. parecoxib and valdecoxib |
| 06/10/2004 | WO2004047814A1 Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor, e.g. parecoxib, valdecoxib and benzopyran derivatives |
| 06/10/2004 | WO2004047812A1 Hollow nanoparticles of protein and drug using the same |
| 06/10/2004 | WO2004047811A1 Controlled release formulation of tamsulosin or pharmaceutically acceptable salts thereof for treatment of the signs and symptoms of benign prostatic hyperplasia |